Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2013; 19(23): 3649-3657
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3649
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3649
Figure 1 Kaplan-Meier curve shows overall survival rates of different treatment modalities in hepatocellular carcinoma patients who survived between 5 years and 10 years.
Different treatment models showed statistically significant differences in the survival period: surgery alone > surgery-transcatheter arterial chemoembolization (TACE) > TACE-radiofrequency ablation (RFA) > TACE alone > surgery-TACE-RFA.
- Citation: Wu KT, Wang CC, Lu LG, Zhang WD, Zhang FJ, Shi F, Li CX. Hepatocellular carcinoma: Clinical study of long-term survival and choice of treatment modalities. World J Gastroenterol 2013; 19(23): 3649-3657
- URL: https://www.wjgnet.com/1007-9327/full/v19/i23/3649.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i23.3649